替米沙坦(telmisartan)单独和与雷米普利(ramipril)联用的全球终点试验(ONgoing Telmisartan Alone and in combina-tion with Ramipril Global Endpoint Trial,ONTARGET)是一项关于替米沙坦对雷米普利非劣性设计的临床试验研究。HOPE研究证明了血管紧张素转换酶抑制剂(ACEI)雷 ONgoing Telmisartan Alone and in combina tion with Ramipril Global Endpoint Trial (ONTARGET), telmisartan alone and in combination with ramipril, Clinical Trial Study of Mipril Noninferiority Design. HOPE studies have demonstrated angiotensin-converting enzyme inhibitor (ACEI) thunder